Norpramin (desipramine hydrochloride) – Dear Healthcare Professional Letter
Audience: Psychiatric healthcare professionals
Sanofi-Aventis and FDA notified healthcare professionals of changes to the Warnings and Overdosage sections of the Prescribing Information for Norpramin (desipramine hydrochloride), indicated for the…
Related posts:
- Ultram (tramadol hydrochloride), Ultracet (tramadol hydrochloride/acetaminophen): Label Change Audience: Pain management healthcare professionals [Posted 05/25/2010] Ortho-McNeil-Janssen and FDA...
- Lexiva (fosamprenavir calcium) – Dear Healthcare Professional Letter Audience: HIV/Infectious Disease healthcare professionals, cardiovascular healthcare professionals GlaxoSmithKline and...
- Depression Drug Norpramin Linked to Fatal Heart Complications, FDA Warns The Food and Drug Administration and drugmaker Sanofi-Aventis are telling...
- Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review Audience: Cardiology and endocrinology healthcare professionals FDA notified healthcare professionals...
- Promethazine Hydrochloride Injection Audience: All healthcare professionals FDA notified healthcare professionals that a...
Permalink Tags: Dangerous Drugs
